Institutional investors purchased a net $3.1 million shares of INCY during the quarter ended June 2015 and now own 95.77% of the total shares outstanding. This majority interest is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
CAPITAL RESEARCH & MANAGEMENT CO... Bought 1.1 Million shares of Incyte Corp
THE VANGUARD GROUP, INC. Bought 772.0 Thousand shares of Incyte Corp
WELLS CAPITAL MANAGEMENT, INC. Bought 721.8 Thousand shares of Incyte Corp